Germany-based Siemens Healthineers AG (ETR: SHL) has announced the completion of its acquisition of Advanced Accelerator Applications (AAA) Molecular Imaging from Novartis (NYSE: NVS). This strategic move is anticipated to significantly enhance Siemens’ PETNET Solutions sector, strengthening its position in the field of positron emission tomography (PET) and radiopharmaceuticals.
Enhancing Siemens’ PETNET Solutions Sector
Based in Europe, AAA is a leading company focused on the manufacturing and sales of radiopharmaceuticals for PET. The acquisition of AAA Molecular Imaging is set to bolster Siemens Healthineers’ PETNET Solutions, which already operates 47 PET radiopharmaceuticals pharmacies in the US and has a combined 13 manufacturing plants in France, Spain, Portugal, Italy, and Germany, along with a distribution network in Switzerland.
PETNET Solutions: A Leader in Integrated Diagnosis and Treatment
PETNET Solutions, a segment of Siemens Healthineers’ Molecular Imaging business, is known for producing diagnostic reagents that support integrated diagnosis and treatment. This innovative approach to personalized cancer treatment is set to benefit from the expanded capabilities and expertise that AAA brings to the table.-Fineline Info & Tech
